Rees J. Can one drug be discontinued in combination therapy for LUTS? Practitioner 2014 ; 258 (1769): 8
Can one drug be discontinued in combination therapy for LUTS?
20 Mar 2014
Patients with BPH being treated with combination therapy for LUTS are more likely to be able to stop the alpha blocker treatment than the 5-alpha reductase inhibitor (5-ARI), a study from Taiwan suggests.[With external links to the current evidence base]
This article can be accessed only if you are a paid-up subscriber to The Practitioner.

= Registered users